Pieris Pharma (PIRS) Tops Q1 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. CMG
7. TENB
8. BIIB
9. KLAC
10. ETSY

Go back to Pieris Pharma (PIRS) Tops Q1 EPS by 2c

Pieris Pharmaceuticals Reports Financial Results and Corporate Update for the First Quarter Ended March 31, 2016

May 11, 2016 5:00 PM EDT

BOSTON, MA -- (Marketwired) -- 05/11/16 -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for cancer and other diseases, today reported financial results for the first quarter of 2016 and provided an update on the Company's recent developments.

"During the first quarter, we made substantial progress across both our pipeline and partnerships, in our continued efforts to build a world class... More